XML 21 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flow - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating Activities:    
Net income (loss) attributable to common stockholders $ 28,581 $ (60,007)
Net income (loss) attributable to non-controlling interests 2,059 (563)
Net income (loss) 30,640 (60,570)
Adjustments to reconcile net income to net cash provided by (used in) operating activities    
Net realized and unrealized (gains) losses (69,371) 62,441
Net (gain) loss on sale of businesses 431 0
Non-cash compensation expense 1,065 1,616
Amortization/accretion of premiums and discounts 670 424
Depreciation and amortization expense 5,934 3,863
Non-cash lease expense 2,195 2,133
Amortization of deferred financing costs 394 169
Loss on extinguishment of debt 0 353
Deferred provision (benefit) for income taxes 7,788 (17,929)
Other 80 60
Changes in operating assets and liabilities:    
Mortgage loans originated for sale (911,193) (539,970)
Proceeds from the sale of mortgage loans originated for sale 956,609 609,125
(Increase) decrease in notes and accounts receivable 24,507 (17,467)
(Increase) decrease in reinsurance receivables 14,279 30,217
(Increase) decrease in deferred acquisition costs (43,494) (10,328)
(Increase) decrease in other assets (4,101) (5,201)
Increase (decrease) in unearned premiums 31,319 (26,474)
Increase (decrease) in policy liabilities and unpaid claims 17,885 (206)
Increase (decrease) in deferred revenue 25,397 27,453
Increase (decrease) in reinsurance payable (23,329) (23,431)
Increase (decrease) in other liabilities and accrued expenses (40,375) (11,066)
Net cash provided by (used in) operating activities 27,330 25,212
Investing Activities:    
Purchases of investments (413,159) (168,125)
Proceeds from sales and maturities of investments 372,015 114,881
Proceeds from the sale of real estate 0 389
Purchases of property, plant and equipment (397) (1,455)
Proceeds from the sale of businesses 125 125
Proceeds from notes receivable 14,762 7,739
Issuance of notes receivable (15,710) (20,996)
Business and asset acquisitions, net of cash, restricted cash and deposits [1] 0 20,136
Net cash provided by (used in) investing activities (42,364) (47,306)
Financing Activities:    
Dividends paid (1,326) (1,415)
Non-controlling interest contributions 100 0
Non-controlling interest distributions 0 (792)
Payment of debt issuance costs 0 (1,441)
Proceeds from borrowings and mortgage notes payable 955,306 750,861
Principal paydowns of borrowings and mortgage notes payable (952,260) (713,607)
Repurchases of common stock (2,450) (3,945)
Net cash provided by (used in) financing activities (630) 29,661
Net increase (decrease) in cash, cash equivalents and restricted cash (15,664) 7,567
Cash, cash equivalents and restricted cash – beginning of period 195,275 144,590
Cash, cash equivalents and restricted cash – beginning of period - held for sale 4,879 7,137
Cash, cash equivalents and restricted cash – end of period 177,173 154,201
Supplemental Schedule of Non-Cash Investing and Financing Activities:    
Right of use asset obtained in exchange for lease liability 1,413 513
Reconciliation of cash, cash equivalents and restricted cash    
Total cash, cash equivalents and restricted cash shown in the statements of cash flows $ 195,275 $ 154,201
[1] (1)    Changes in balance sheet balances due to acquisitions have been netted down in the respective line items. See Note (3) Acquisitions for additional information.